Science & Enterprise subscription

Follow us on Twitter

  • A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of… https://t.co/KRVGnVRxpC
    about 7 hours ago
  • New post on Science and Enterprise: Study Testing Wearables Data for Covid-19 Clues https://t.co/Ybk48QXn0U #Science #Business
    about 7 hours ago
  • The developer of an antibody cocktail to treat non-hospitalized Covid-19 patients released first results from a cli… https://t.co/YGxzmClqvT
    about 15 hours ago
  • New post on Science and Enterprise: Mixed Early Results in Covid-19 Antibody Cocktail Trial https://t.co/riNupxXBki #Science #Business
    about 15 hours ago
  • A new enterprise is creating thin films for vaccines, including Covid-19, to make possible their mass production an… https://t.co/gPWJ3Rm9Vm
    about 1 day ago

Please share Science & Enterprise

Non-Invasive Hemoglobin Anemia Screening System Unveiled

Red blood cell (science360.gov)

Red blood cell (science360.gov)

OrSense Ltd., a medical device developer in Israel, has introduced a wireless, non-invasive hemoglobin measurement system for anemia monitoring, hemorrhage detection, and pre-donation blood screening. The company revealed the new product at a meeting of the International Society of Blood Transfusion in Cancun, Mexico.

Hemoglobin is a protein in red blood cells that carries oxygen. Hospitals and blood donation centers require hemoglobin measurements to protect against blood with low hemoglobin, such as from people with anemia, from entering the supply chain. Most current tests require the physical drawing of blood, which can be painful for some patients or difficult in emergencies.

OrSense’s new device, called Glasswing, is a wireless system that can take continuous or occasional hemoglobin measurements from a patient without drawing blood. The system uses an optical ring-shaped sensor that goes on a patient’s finger. The sensor applies gentle pressure to the patient’s finger, slightly restricting blood flow, which allows for optical measurements of blood properties, including hemoglobin counts.

The Glasswing system then collects the data for online storage or downloading. The company says the data can be transferred in real time to electronic medical records or digitally-enabled monitoring systems in primary care offices, critical care and emergency facilities, blood donation centers, women’s health clinics, and home health care providers.

OrSense says the system offers other advantages, notably reduced need for trained staff to take measurements, and the absence of bio-hazardous waste associated with the drawing of blood for traditional hemoglobin tests.

Read more:

*     *     *

Comments are closed.